SHELTON JERRELL 4
4 · Cryoport, Inc. · Filed Mar 25, 2026
Research Summary
AI-generated summary of this filing
Cryoport (CYRX) CEO Jerrell Exercises Options, Sells Shares
What Happened
- Jerrell Shelton, President, CEO and Director of Cryoport (CYRX), exercised 25,000 stock options on March 23, 2026 at $1.87 per share (total cost $46,750). The Form 4 also shows a related derivative disposition of 25,000 shares at $0. On the same day he sold 2,894 shares in an open market/private sale at $8.18 each, generating $23,673; footnotes indicate those shares were sold to satisfy tax withholding requirements upon vesting.
Key Details
- Transaction date(s): March 23, 2026; Form 4 filed March 25, 2026 (reporting appears timely).
- Option exercise: 25,000 shares acquired @ $1.87 — $46,750 total.
- Derivative disposition: 25,000 shares disposed @ $0 (listed as conversion/disposition in filing).
- Open-market/private sale: 2,894 shares sold @ $8.18 — $23,673 total.
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Footnotes: F1 — shares sold to pay taxes due upon vesting of restricted stock rights; F2 — original options vested 1/48 monthly beginning May 6, 2016.
- No 10b5-1 or gifting notation; sale appears tax-related rather than a discretionary liquidity sale.
Context
- The primary action was an option exercise (insider converting options into shares). The separate $0 disposal line is reported as a derivative conversion in the filing and commonly appears when exercised shares are transferred or surrendered as part of the exercise/withholding process. The small sale of 2,894 shares was explicitly for tax withholding per the footnote, a routine administrative transaction that doesn’t necessarily signal a change in insider sentiment.
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
SHELTON JERRELL
DirectorPresident, CEO
Transactions
- Sale
Common Stock
[F1]2026-03-23$8.18/sh−2,894$23,673→ 1,051,607 total - Exercise/Conversion
Common Stock
2026-03-23$1.87/sh+25,000$46,750→ 1,076,607 total - Exercise/Conversion
Options to purchase common stock
[F2]2026-03-23−25,000→ 154,007 totalExercise: $1.87Exp: 2026-05-06→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- [F2]1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
Signature
/s/ Jerrell Shelton|2026-03-25